Clinical Blog
Published: February 16, 2022

Latest Propeller Health findings on asthma care to be presented at AAAAI 2022

This year, the American Academy of Allergy, Asthma and Immunology (AAAAI) has accepted four abstracts authored by Propeller Health and its research partners.

Our latest findings on asthma care, including how simplified dose frequency may increase medication adherence and how digital health can support improved pediatric asthma outcomes, will be presented at the AAAAI Annual Meeting on February 25-28. Read brief summaries of each abstract below or click the links to view them online.

Differences in medication adherence by dosing schedule among patients with asthma

Presented by Propeller and our research partner, Children’s Hospital Colorado

Summary: Patients with asthma may be prescribed once- or twice-daily dosing of controller inhalers. Researchers assessed differences in objectively-recorded medication adherence by dosing schedule and age. Among the study group, those who were prescribed once-daily dosing schedules were significantly more likely to adhere to their controller medications compared to those with twice-daily schedules. This finding held true even when controlling for age. 

View this abstract online. 

Feasibility of capturing self-reported asthma exacerbations with a digital self-management platform

Presented by Propeller

Summary: A primary goal of asthma care is reducing exacerbation risk. Propeller found that monthly self-report surveys conducted through its digital health app for chronic respiratory disease may be a feasible way to capture information about acute care events, including emergency department visits and hospitalizations. Combining insights from inhaler use trends and self-reported exacerbations may support early prediction of symptom worsening in patients with asthma. 

View this abstract online. 

Changes in remote care adoption for asthma during the COVID-19 pandemic

Presented by Propeller

Summary: The COVID-19 pandemic led to greater adoption of virtual and remote care. Propeller sought to understand which remote care tools and monitoring devices patients with asthma used and whether they perceived value in their virtual care. Survey results indicate patients used a myriad of remote tools for their asthma management during the COVID-19 pandemic, such as televisit platforms and online prescription services, and that the majority were generally satisfied with remote care. 

View this abstract online. 

Impact of electronic medication monitoring on pediatric asthma severity and control in a real-world multidisciplinary clinic

Presented by our research partner, Children’s Hospital Colorado

Summary: Compared to adult asthma, the impact of electronic medication monitoring (EMM) on pediatric asthma outcomes has not been well described in research. This study assessed changes in asthma severity, control, and rescue inhaler use after 6 months of EMM use in real-world, poorly controlled pediatric asthma patients. Researchers found that the use of an EMM in pediatric patients – as part of a multidisciplinary care plan – was associated with improved asthma control and decreased rescue inhaler use. 

View this abstract online. 

For any questions about Propeller’s peer-reviewed clinical research, please reach out to

You Might Also Like

Webinar Recap: The Past, Present, and Future of Digital Health With the National Academy of Medicine
The use of remote monitoring devices among physicians has doubled to 30% — a 150% increase since 2016.1 While the rise of technology utilization in healthcare is promising, the industry’s digital transformation is far from over. As organizations continue to integrate digital health solutions into clinical workflows, they must also expand their understanding of everything […]
Advancing Equity for Respiratory Patients Through Public Health Research: Insights From ATS 2023 (Part Three)
Health disparities in respiratory care continue to disproportionately affect low-income individuals, people of color, and those living in areas with poor air quality. With new requirements from NCQA, HEDIS, and CMS, maintaining equal access to quality care has become of even greater importance for healthcare systems. Propeller Health and ResMed presented several abstracts at the […]
Leveraging Claims Data to Personalize Treatment Plans: Insights From ATS 2023 (Part Two)
Analyzing national administrative claims data can provide insights into patient behaviors and outcomes, which clinical teams can leverage to develop more personalized treatment plans and improve outcomes among high-risk patients. Propeller Health and ResMed presented several abstracts at the ATS 2023 International Conference in Washington D.C. on May 19-24, many of which used asthma- and […]